Literature DB >> 385620

Reticulate bodies as single antigen in Chlamydia trachomatis serology with microimmunofluorescence.

E C Yong, J S Chinn, H D Caldwell, C C Kuo.   

Abstract

Formalin-fixed, purified reticulate bodies (RB) of Chlamydia trachomatis immunotype C/TW-3/OT were used as a serological test antigen in the microimmunofluorescence test. The sensitivity and specificity of the RB antigen were compared to elementary bodies (EB) used as antigens in the detection of C. trachomatis antibodies in human sera by microimmunofluorescence. RB reacted with all known C. trachomatis immunotypes with the same sensitivity as the homotypic EB. In routine serology with sera and endocervical secretions, the RB antigen had a sensitivity similar to that of the EB in detecting serum antibodies, endocervical secretion antibodies, and antibodies of immunoglobulin M and G classes. No false-positive reactions were detected with control sera. All positive reactions showed type-specific antibodies against an EB immunotype. RB seemed to demonstrate chlamydial group reactivity; sera from 10 psittacosis patients diagnosed clinically and serologically by complement fixation showed five positive, three equivocal, and two negative reactions. By immunofluorescence, RB appeared as distinct rings demonstrating uniform peripheral surface fluorescence at their rims. The EB appeared as pinpoint-sized dots. C/TW-3/OT RB used as a single test anitgen should provide a simple and sensitive serological assay for the detection of C. trachomatis antibody.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 385620      PMCID: PMC273168          DOI: 10.1128/jcm.10.3.351-356.1979

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  14 in total

1.  Some properties of the complement-fixing antigens of the agents of trachoma and inclusion blennorrhoea and the relationship of the antigens to the developmental cycle.

Authors:  P REEVE; J TAVERNE
Journal:  J Gen Microbiol       Date:  1962-03

2.  Etiology of nongonococcal urethritis.

Authors:  K K Holmes; H H Handsfield; S P Wang; B B Wentworth; M Turck; J B Anderson; E R Alexander
Journal:  N Engl J Med       Date:  1975-06-05       Impact factor: 91.245

Review 3.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Human serology in Chlamydia trachomatis infection with microimmunofluorescence.

Authors:  S P Wang; J T Grayston
Journal:  J Infect Dis       Date:  1974-10       Impact factor: 5.226

5.  Three new immunologic types of trachoma-inclusion conjunctivitis organisms.

Authors:  S P Wang; J T Grayston; J L Gale
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

6.  TRIC type K, a new immunologic type of Chlamydia trachomatis.

Authors:  C C Kuo; S P Wang; J T Grayston; E R Alexander
Journal:  J Immunol       Date:  1974-08       Impact factor: 5.422

7.  Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci.

Authors:  H D Caldwell; C C Kuo; G E Kenny
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

8.  Single-antigen immunofluorescence test for chlamydial antibodies.

Authors:  P Saikku; J Paavonen
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

9.  Serologic diagnosis of Lymphogranuloma venereum by counterimmunoelectrophoresis with a Chlamydia trachomatis protein antigen.

Authors:  H D Caldwell; C C Kuo
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

10.  Enzyme-linked immunosorbent assay for chlamydial antibodies.

Authors:  V J Lewis; W L Thacker; S H Mitchell
Journal:  J Clin Microbiol       Date:  1977-11       Impact factor: 5.948

View more
  16 in total

1.  Staining of surface antigens of Chlamydia trachomatis L2 in tissue culture.

Authors:  M Baumann; L Brade; E Fasske; H Brade
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

2.  Ultrastructural study of Chlamydia trachomatis surface antigens by immunogold staining with monoclonal antibodies.

Authors:  C C Kuo; E Y Chi
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

3.  Immunodiagnosis of ocular chlamydial infection.

Authors:  A Rahi; A Rashood; S Rahi; K F Tabbara; A al-Jama
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

4.  Solid-phase enzyme immunoassay for Chlamydial antibodies.

Authors:  P Saikku; J Paavonen; P Väänänen; A Vaheri
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

5.  Chlamydial antigens stabilized with formalin for use in the micro-immunofluorescence test.

Authors:  L Hanna; H Keshishyan
Journal:  J Clin Microbiol       Date:  1980-09       Impact factor: 5.948

6.  Detection of IgM antibodies against Chlamydia trachomatis by enzyme linked fluorescence immunoassay.

Authors:  K Numazaki; S Chiba; T Yamanaka; T Moroboshi; K Aoki; T Nakao
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

7.  A study of human respiratory tract chlamydial infections in Cambridgeshire 1986-88.

Authors:  T G Wreghitt; C E Barker; J D Treharne; J M Phipps; V Robinson; R B Buttery
Journal:  Epidemiol Infect       Date:  1990-06       Impact factor: 2.451

8.  Localization of distinct surface antigens on Chlamydia trachomatis HAR-13 by immune electron microscopy with monoclonal antibodies.

Authors:  R B Clark; I Nachamkin; P F Schatzki; H P Dalton
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

9.  Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans.

Authors:  R C Brunham; D H Martin; C C Kuo; S P Wang; C E Stevens; T Hubbard; K K Holmes
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

10.  Analysis of the human serological response to proteins of Chlamydia trachomatis.

Authors:  W J Newhall; B Batteiger; R B Jones
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.